Benefits and Harms of Risk-Reducing Medication (Tamoxifen), Screening Mammography, and Supplemental Screening With Magnetic Resonance Imaging in 35-, 50-, and 65-Year-Old Women on the Basis of History of Breast Biopsy and Family History of Breast Cancer